![]() Summit Therapeutics Summit Therapeutics is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat the fatal muscle wasting disease Duchenne muscular dystrophy and infections caused by the bacteria C. difficile. | ![]() Sun Pharma Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company. | ![]() Divis Laboratories Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. | |||
Founding Date | Founding Date 2003 | Founding Date 1901 | Founding Date 1983 | Founding Date 1971 | Founding Date 1990 |
Type | Type Public | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Miami, US HQ Abingdon, GB Menlo Park, US | Locations HQ | Locations Mumbai, IN HQ Macquarie Park, AU Dhaka, BD Goiânia, BR Goiânia, BR São Paulo, BR Brampton, CA see more | Locations Ahmedabad, IN HQ São Paulo, BR Nürnberg, DE 32 No Market, IN Bengaluru, IN Chennai, IN Dahej, IN see more | Locations Hyderabad, IN HQ Choutuppal, IN Thondangi, IN Visakhapatnam, IN Basel, CH Basel, CH Florham Park, US |
Employees | Employees 105 | Employees 29,780 | Employees 43,000 | Employees 15,718 | Employees 7,9267% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ₹582.2b (FY, 2026) | Revenue (est.) ₹137.5b (FY, 2026) | Revenue (est.) ₹105.6b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ₹115.4b (FY, 2026) | Cost of goods ₹33.9b (FY, 2026) | Cost of goods ₹40.9b (FY, 2026) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ₹488.9b (FY, 2026) | Gross profit ₹105b (FY, 2026) | Gross profit ₹69.7b (FY, 2026) |
Net income | Net income ($1.1b) (FY, 2025) | Net income N/A | Net income ₹115.6b (FY, 2026) | Net income ₹21.4b (FY, 2026) | Net income ₹25.7b (FY, 2026) |

Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.
View company
Manufactures wide range of pharmaceutical products.
View company
Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates.
View company